Literature DB >> 25055976

Gender differences in the expression of genes involved during cardiac development in offspring from dams on high fat diet.

Maqsood M Elahi1, Bashir M Matata.   

Abstract

Previously we have demonstrated that maternal high fat diet (HF) during pregnancy increase cardiovascular risk in the offspring, and pharmacological intervention using statins in late pregnancy reduced these risk factors. However the effects of maternal HF-feeding and statin treatment during pregnancy on development of heart remain unknown. Hence we measured expression of genes involved in cell cycle progression (cyclin G1), ventricular remodelling brain natriuretic peptide (BNP), and environmental stress response small proline-rich protein 1A (SPRR 1A) in the offspring left ventricle (LV) from dams on HF with or without statin treatment. Female C57 mice were fed a HF diet (45% kcal fat) 4 weeks prior to conception, during pregnancy and lactation. From the second half of the pregnancy and throughout lactation, half of the pregnant females on HF diet were given a water-soluble statin (Pravastatin) in their drinking water (HF + S). At weaning offspring were fed HF diet to adulthood (generating dam/offspring dietary groups HF/HF and HF + S/HF). These groups were compared with offspring from dams fed standard chow (C 21% kcal fat) and fed C diet from weaning (C/C). LV mRNA levels for cyclin G1, BNP and SPRR 1A were measured by RT-PCR. Heart weights and BP in HF/HF offspring were higher versus C/C group. Maternal Pravastatin treatment reduced BP and heart weights in HF + S/HF female offspring to levels found in C/C group. LV cyclin G1 mRNA levels were lower in HF/HF versus both C/C and HF + S/HF offspring. BNP mRNA levels were elevated in HF/HF females but lower in males versus C/C. BNP gene expression in HF + S/HF offspring was similar to HF/HF. SPRR 1A mRNA levels were similar in all treatment groups. Statins given to HF-fed pregnant dams reduced cardiovascular risk in adult offspring, and this is accompanied by changes in expression of genes involved in adaptive remodelling in the offspring LV and that there is a gender difference.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25055976     DOI: 10.1007/s11033-014-3605-8

Source DB:  PubMed          Journal:  Mol Biol Rep        ISSN: 0301-4851            Impact factor:   2.316


  24 in total

Review 1.  Cell cycle regulatory molecules (cyclins, cyclin-dependent kinases and cyclin-dependent kinase inhibitors) and the cardiovascular system; potential targets for therapy?

Authors:  J M Li; G Brooks
Journal:  Eur Heart J       Date:  1999-03       Impact factor: 29.983

2.  Maternal nutrient restriction alters gene expression in the ovine fetal heart.

Authors:  Hyung-Chul Han; Kathleen J Austin; Peter W Nathanielsz; Stephen P Ford; Mark J Nijland; Thomas R Hansen
Journal:  J Physiol       Date:  2004-05-07       Impact factor: 5.182

Review 3.  The role of natriuretic peptides in cardioprotection.

Authors:  Toshio Nishikimi; Nobuyo Maeda; Hiroaki Matsuoka
Journal:  Cardiovasc Res       Date:  2005-11-10       Impact factor: 10.787

4.  Coronary heart disease after prenatal exposure to the Dutch famine, 1944-45.

Authors:  T J Roseboom; J H van der Meulen; C Osmond; D J Barker; A C Ravelli; J M Schroeder-Tanka; G A van Montfrans; R P Michels; O P Bleker
Journal:  Heart       Date:  2000-12       Impact factor: 5.994

5.  Dietary protein restriction in pregnancy induces hypertension and vascular defects in rat male offspring.

Authors:  Lee Brawley; Shigeru Itoh; Christopher Torrens; Alison Barker; Caroline Bertram; Lucilla Poston; Mark Hanson
Journal:  Pediatr Res       Date:  2003-03-19       Impact factor: 3.756

6.  Chronic phospholamban inhibition prevents progressive cardiac dysfunction and pathological remodeling after infarction in rats.

Authors:  Yoshitaka Iwanaga; Masahiko Hoshijima; Yusu Gu; Mitsuo Iwatate; Thomas Dieterle; Yasuhiro Ikeda; Moto-o Date; Jacqueline Chrast; Masunori Matsuzaki; Kirk L Peterson; Kenneth R Chien; John Ross
Journal:  J Clin Invest       Date:  2004-03       Impact factor: 14.808

Review 7.  Fetal programming of coronary heart disease.

Authors:  David J P Barker
Journal:  Trends Endocrinol Metab       Date:  2002-11       Impact factor: 12.015

Review 8.  Fetal programming of cardiovascular function through exposure to maternal undernutrition.

Authors:  S C Langley-Evans
Journal:  Proc Nutr Soc       Date:  2001-11       Impact factor: 6.297

9.  Nature of fatty acids in high fat diets differentially delineates obesity-linked metabolic syndrome components in male and female C57BL/6J mice.

Authors:  Souhad El Akoum; Vikie Lamontagne; Isabelle Cloutier; Jean-François Tanguay
Journal:  Diabetol Metab Syndr       Date:  2011-12-14       Impact factor: 3.320

10.  The programming of cardiac hypertrophy in the offspring by maternal obesity is associated with hyperinsulinemia, AKT, ERK, and mTOR activation.

Authors:  Denise S Fernandez-Twinn; Heather L Blackmore; Lee Siggens; Dino A Giussani; Christine M Cross; Roger Foo; Susan E Ozanne
Journal:  Endocrinology       Date:  2012-10-15       Impact factor: 4.736

View more
  4 in total

1.  Foetal hypoxia impacts methylome and transcriptome in developmental programming of heart disease.

Authors:  Lei Huang; Xin Chen; Chiranjib Dasgupta; Wanqiu Chen; Rui Song; Charles Wang; Lubo Zhang
Journal:  Cardiovasc Res       Date:  2019-07-01       Impact factor: 10.787

2.  High Dietary Fat and Selenium Concentrations Exert Tissue- and Glutathione Peroxidase 1-Dependent Impacts on Lipid Metabolism of Young-Adult Mice.

Authors:  Zeping Zhao; Jonggun Kim; Xin Gen Lei
Journal:  J Nutr       Date:  2020-07-01       Impact factor: 4.798

3.  Myocardial-specific ablation of Jumonji and AT-rich interaction domain-containing 2 (Jarid2) leads to dilated cardiomyopathy in mice.

Authors:  Eunjin Cho; HyunJun Kang; Dae-Ki Kang; Youngsook Lee
Journal:  J Biol Chem       Date:  2019-01-30       Impact factor: 5.157

Review 4.  Effects of Maternal Obesity on Fetal Programming: Molecular Approaches.

Authors:  Caterina Neri; Andrea G Edlow
Journal:  Cold Spring Harb Perspect Med       Date:  2015-09-03       Impact factor: 6.915

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.